Investment Rating - The report maintains an "Outperform" rating for the company [5] Core Views - The integration of Sinochem Blue Sky has significantly enhanced the company's profits, with the refrigerant business providing performance elasticity. The future of the chemical new materials platform looks promising [5] - The company reported a revenue of 10.207 billion yuan for Q3 2024, a year-on-year decrease of 12%, while the net profit attributable to shareholders was 851 million yuan, down 19% year-on-year. The integration of Sinochem Blue Sky contributed 4.946 billion yuan in revenue and 328 million yuan in net profit [5][6] - The report highlights the positive impact of the refrigerant business, which has seen a recovery in profitability, with net profit from Sinochem Blue Sky increasing over sixfold year-on-year [5] Financial Summary - For Q3 2024, the company achieved a revenue of 10.207 billion yuan, with a year-on-year decline of 12%. The net profit attributable to shareholders was 851 million yuan, down 19% year-on-year [6] - The projected revenues for 2024-2026 are 14.704 billion yuan, 16.634 billion yuan, and 18.672 billion yuan respectively, with corresponding net profits of 1.294 billion yuan, 1.963 billion yuan, and 2.513 billion yuan [6][8] - The gross profit margin for Q3 2024 was 22.7%, with an expected increase to 25.6% in 2024 [6] Business Segmentation - The report details the performance of the two segments: Haohua Technology and Sinochem Blue Sky. Haohua Technology faced challenges due to declining prices of fluoropolymer products and rising raw material costs, leading to a 15.64% decrease in net profit [5] - Sinochem Blue Sky's refrigerant business benefited from favorable quota policies, significantly enhancing profitability. The report notes that the average domestic price of mainstream refrigerants is expected to rise in Q4 2024 [5][6]

Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [1]. Core Insights - The company has shown significant profit growth due to the acquisition of Sinochem Blue Sky, which has enhanced its overall profitability and business structure [4]. - The refrigerant products have experienced both volume and price increases, contributing to a substantial rise in net profit for the third quarter of 2024 [3][4]. - The company is actively strengthening its core technology and advancing ongoing projects, with a total of 228 patents applied for in 2024 [5]. Financial Performance Summary - In Q3 2024, the company achieved a net profit of 315 million yuan, a year-on-year increase of 53.40%, primarily due to the acquisition of Sinochem Blue Sky [2]. - For the first three quarters of 2024, the company reported revenue of 10.207 billion yuan, a decrease of 11.61% year-on-year, and a net profit of 851 million yuan, down 18.60% year-on-year [3]. - The sales gross margin for the first three quarters was 22.73%, a decline of 2.31 percentage points year-on-year [3]. Future Projections - The company is projected to achieve revenues of 14.245 billion, 16.495 billion, and 19.184 billion yuan for the years 2024, 2025, and 2026, respectively, with corresponding net profits of 1.198 billion, 1.491 billion, and 1.926 billion yuan [8]. - The expected growth rates for revenue and net profit are 81% and 33% for 2024, respectively, indicating a strong recovery trajectory [8]. Market Position - As of November 4, 2024, the company's stock price is 34.12 yuan, with a market capitalization of approximately 37.82 billion yuan [2][10]. - The company has outperformed the CSI 300 index over the past month, with a return of 7.5% compared to a decline of 1.8% for the index [2].

可以的全部或部分内容 版权所有 未得利证谢谢会议助理 尊敬的各位投资者 大家上午好我是中兴电脑的化工研究员周冲非常欢迎大家参加咱们浩华科技的一个三级报的业绩要求会公司也是已经发布了三级报整个中华蓝天也是已经成功的定表然后我们今天也是很高兴的邀请到了公司的董秘书总 然后生产经营部的主任王总然后正在吴总来在今天与我们参加交流然后就公司包括整个中化蓝天的一些经营情况以及未来的一个展望来做一个交流那我们先这个领导介绍一下整体的一个情况苏总好的谢谢周周谢谢各位投资者也欢迎大家欢迎和感谢大家对关注豪华科技 我还是先做一个大体一个小介绍就是花花科技是2018年底实施了增大资产重组近几年来我们是明确了我们的主营业务那就是3加1的核心业务高端活材料电子化学品 高端制造化工材料以及这个加一的碳碱排业务那么也明确了我们的就是说战略定位呢是叫这个全国一流的创新型的先进化工材料解决方案提供商我们在21年的时候呢有发布一个十四五规划对每一个板块呢都做了未来十四五规划的一个目标其中关于高端活材料这块呢当时就是 定的目标要是在十四五成为这个就是全国一流的当时是叫具有完整产业链的一流的这个高端活材料的供应商其实呢我们一直也在往这个目标前进就刚 ...

PAN-CHINA Certified Public Accountants 关于中化蓝天集团有限公司 资产交割过渡期合并利润表的 专项审计报告 PAN-CHINA 天健会计师事务所 Pan-China Certified Public Accountants 资产交割过渡期合并利润表的专项审计报告 天健审〔2024〕10595 号 昊华化工科技集团股份有限公司: 一、审计意见 我们接受贵公司委托,审计了中化蓝天集团有限公司(以下简称中化蓝天公 司）2023年１月１日至 2024年７月 18 日的资产交割过渡期合并利润表〈以下 简称过渡期合并利润表),以及过渡期合并利润表附注。 我们认为,后附的过渡期合并利润表在所有重大方面按照过渡期合并利润表 附注三所述的编制基础编制, 公允反映了中化蓝天公司在过渡期 2023 年 1 月 1 日至 2024 年 7 月 18 日的经营成果。 ■ 景 | 一、专项审计报告 第 1-4 页 | | --- | | 二、资产交割过渡期合并利润表 | | 三、资产交割过渡期合并利润表附注………………………………………… 第 6―35 页 | | ················· ...

证券代码：600378 证券简称：昊华科技 公告编号：临 2024-077 昊华化工科技集团股份有限公司 关于公司发行股份购买资产并募集配套资金暨关联交易 之标的资产过渡期间损益情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 昊华化工科技集团股份有限公司（以下简称"公司"或"上市公司"）以发行股 份的方式购买中国中化集团有限公司（以下简称"中化集团"）、中化资产管理有限 公司（以下简称"中化资产"）所持中化蓝天集团有限公司（以下简称"中化蓝天" 或"标的公司"）合计 100%股权（以下简称"标的资产"），同时拟向包括中国对 外经济贸易信托有限公司、中化资本创新投资有限公司在内的不超过 35 名符合条件 的特定投资者非公开发行股份募集配套资金（以下简称"本次交易"）。 2024 年 6 月 20 日，中国证券监督管理委员会已出具《关于同意昊华化工科技集 团股份有限公司发行股份购买资产并募集配套资金注册的批复》（证监许可〔2024〕 964 号），同意本次交易的注册申请。截至 2024 年 7 月 18 日，中化集团持 ...

证券代码：600378 证券简称：昊华科技 公告编号：临 2024-075 昊华化工科技集团股份有限公司 2024 年前三季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 昊华化工科技集团股份有限公司（以下简称"公司"）根据《上海 证券交易所上市公司自律监管指引第 3 号——行业信息披露》及附件 《第十三号——化工》要求，现将公司 2024 年前三季度主要经营数 据披露如下： 说明：氟化锂受锂电市场需求不足影响，价格大幅下滑；烟片胶受东南亚停割期 和台风影响，采购价格增幅较大。 主要产品 2024 年 1-9 月平均 售价（元/吨） 2023 年 1-9 月平均 售价（元/吨） 变动比率（%） 氟碳化学品 29,896.48 25,583.71 16.86% 含氟锂电材料 24,216.20 37,043.58 -34.63 含氟聚合物 39,669.81 45,297.80 -12.42 含氟精细化学品 45,568.93 56,266.19 -19.01 含氟气体 94,400.30 107,781.6 ...

证券代码：600378 证券简称：昊华科技 公告编号：临 2024－074 昊华化工科技集团股份有限公司 第八届董事会第二十一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 昊华化工科技集团股份有限公司（以下简称"公司"或"昊华科 技"）第八届董事会第二十一次会议于 2024 年 10 月 29 日以通讯表 决的方式召开。会议通知等材料已于 2024 年 10 月 21 日以电子邮件 并短信通知的方式发送给公司董事、监事、高级管理人员。会议应出 席董事 9 名，实际出席董事 9 名，共收回有效表决票 9 份。会议的召 开符合相关法律、行政法规、部门规章、规范性文件和《公司章程》 的规定。 会议审议并通过如下议案： 一、关于审议《公司 2024 年第三季度报告》的议案 董事会同意《公司 2024 年第三季度报告》。 公司董事会审计委员会已审议通过相关议案。 表决结果：9 票同意，0 票反对，0 票弃权。 《昊华科技 2024 年第三季度报告》详见 2024 年 10 月 31 日上海 证券交易所网站（www.ss ...

证券代码：600378 证券简称：昊华科技 公告编号：临 2024-076 关于召开 2024 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 昊华化工科技集团股份有限公司 重要内容提示： 投资者可于 2024 年 11 月 8 日（星期五）至 11 月 14 日（星期 四）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或 通过公司邮箱 hhkj@sinochem.com 进行提问。公司将在说明会上 对投资者普遍关注的问题进行回答。 昊华化工科技集团股份有限公司（以下简称"公司"）已于 2024 年 10 月 31 日发布《昊华科技 2024 年第三季度报告》。为便于广大投资 者更全面、更深入地了解公司 2024 年第三季度经营成果、财务状况， 公司计划于 2024 年 11 月 15 日（星期五）上午 10:00-11:00 举行 2024 年第三季度业绩说明会，就投资者关心的问题进行交流。 一、说明会类型 本次业绩说明会以网络互动形式召开，公司将针对 2024 年第三 会议召开时间 ...

Financial Performance - The company's operating revenue for Q3 2024 was approximately CNY 3.67 billion, a decrease of 2.02% compared to the same period last year[4]. - Net profit attributable to shareholders for Q3 2024 was approximately CNY 315.18 million, an increase of 53.40% year-on-year[4]. - The basic earnings per share for Q3 2024 was CNY 0.2862, reflecting a 53.38% increase compared to the previous year[4]. - The net profit attributable to shareholders for the year-to-date period decreased by 18.60% compared to the same period last year, totaling approximately CNY 851.14 million[4]. - Total operating revenue for the first three quarters of 2024 was CNY 10,207,054,524.59, a decrease of 11.6% compared to CNY 11,548,377,736.51 in the same period of 2023[23]. - Net profit for the first three quarters of 2024 was CNY 890,814,058.88, a decline of 14.7% from CNY 1,044,765,679.89 in the same period of 2023[25]. - Earnings per share for the first three quarters of 2024 were CNY 0.7705, down from CNY 0.9451 in 2023, indicating a decrease of 18.5%[26]. - The company reported a net profit of 368 million CNY in the first three quarters of 2024, representing a year-on-year growth of 61.68%, with a comprehensive gross margin increase of 4.18 percentage points[16]. - In Q3 2024, the company achieved a net profit of 176 million CNY, a quarter-on-quarter increase of 13.98%[16]. Asset and Liability Management - Total assets at the end of the reporting period were approximately CNY 25.39 billion, an increase of 2.80% from the previous year[5]. - The company's total equity reached CNY 12,900,488,746.90 by the end of Q3 2024, compared to CNY 12,227,879,061.00 in the previous year, marking an increase of 5.5%[22]. - Total liabilities as of the end of Q3 2024 amounted to CNY 13,195,009,586.21, slightly up from CNY 13,157,697,326.70 at the end of Q3 2023[22]. - Non-current liabilities increased to CNY 3,682,697,874.68 in Q3 2024 from CNY 3,242,007,888.76 in Q3 2023, representing a growth of 13.6%[22]. Cash Flow Analysis - The net cash flow from operating activities for the year-to-date period decreased by 54.84% to approximately CNY 382.69 million[4]. - In the first three quarters of 2024, the company generated cash inflows from operating activities totaling ¥9,887,600,984.75, a decrease of approximately 9.9% compared to ¥10,977,413,826.57 in the same period of 2023[27]. - The net cash flow from operating activities for the first three quarters of 2024 was ¥382,687,596.59, down 54.9% from ¥847,479,094.95 in the previous year[28]. - The company reported cash outflows from investing activities of ¥1,550,737,093.62, an increase from ¥1,342,130,227.10 in the same period of 2023[28]. - The net cash flow from investing activities was -¥1,442,881,798.08, compared to -¥316,260,606.06 in the previous year, indicating a significant increase in cash outflow[28]. - Cash inflows from financing activities amounted to ¥7,465,222,208.81, up from ¥4,322,745,573.82 in the same period of 2023[28]. - The company's cash and cash equivalents at the end of the period were ¥1,733,630,163.24, down from ¥2,630,580,114.23 at the end of the same period in 2023[29]. - The company experienced a negative net increase in cash and cash equivalents of -¥1,071,456,294.67 for the first three quarters of 2024, compared to -¥298,954,472.90 in the previous year[29]. Acquisitions and Business Development - The company completed the acquisition of 100% equity in Sinochem Blue Sky Group, which has been consolidated into the company's financial statements since July 2024[6]. - The company completed the acquisition of 100% equity in Zhonghua Lantian, enhancing overall profitability and optimizing business structure[12]. - For the first nine months of 2024, the company achieved a revenue of 10.207 billion RMB, with Zhonghua Lantian contributing 4.946 billion RMB, representing a 93.96% increase compared to before the acquisition[14]. - The net profit attributable to shareholders for the first nine months was 851 million RMB, with Zhonghua Lantian contributing 328 million RMB, marking a 62.82% increase compared to before the acquisition[14]. - In Q3 2024, the company reported a revenue of 3.670 billion RMB, with Zhonghua Lantian contributing 1.814 billion RMB, reflecting a 95.32% increase compared to before the acquisition[14]. - The net profit attributable to shareholders in Q3 reached 315 million RMB, with Zhonghua Lantian contributing 163 million RMB, showing a 105.31% increase compared to before the acquisition[14]. Operational Efficiency and Market Outlook - The comprehensive gross profit margin improved significantly due to the successful implementation of cost reduction and efficiency enhancement measures[9]. - The company's overall gross margin improved by 1.06 percentage points year-on-year in Q3 2024, with a net profit growth of 53.40% year-on-year[15]. - The company reported a 2.02% slight decline in revenue year-on-year for Q3, but the integration of Zhonghua Lantian led to significant improvements in profitability[15]. - The company remains confident in the macroeconomic environment, aiming to leverage internal efficiency and external market potential for high-quality development[13]. - The company plans to accelerate major project construction and enhance internal efficiency to achieve annual operational goals[19]. Shareholder Information - The company has a total of 14,240 common shareholders at the end of the reporting period, with the largest shareholder holding 53.23% of the shares[11]. - The company’s major shareholders include state-owned enterprises, with significant shareholdings and some shares under judicial freeze[11]. Research and Development - The company applied for a total of 228 patents in the first nine months of 2024, including 172 invention patents[18].

证券代码：600378 证券简称：昊华科技 昊华化工科技集团股份有限公司 机构投资者调研记录 （2024 年 9 月 1 日-2024 年 10 月 21 日） 1. 调研时间：2024 年 9 月 1 日-2024 年 10 月 21 日 2. 调研地点：北京及线上 3. 调研形式：现场调研、线上交流 | --- | |----------------------------------------------------------| | | | 4. 机构名称 ：华夏基金、山证化工、国信证券、恒大人寿、 | | 国寿养老、健顺投资、长城财富保险、华宝基金、招商 | | 基金、淡水泉基金、开源证券、申万投资、中金公司 | | （资管）、大成基金、中欧基金、太平基金、长城财富 | | 资管、东海基金、瑞信致远基金、玄卜投资、信银理财、 | | 红杉资本、 Brilliance 才华资本、华夏久盈基金、新华基 | | 金、中国人寿资产、华泰资产、泰康资产、兴证全球基 | | 金、循远资产、朱雀基金、北京和聚私募基金、中国人 | | 寿养老保险、中国人寿资产、海南君阳私募基金、中海 | | 基金、交银理财、中科 ...